A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Egile nagusia: | Islam, Nahidul |
---|---|
Beste egile batzuk: | Talukder, Mesbah |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2023
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/22025 |
Antzeko izenburuak
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
nork: Afroza, Halima
Argitaratua: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
nork: Moya, Amena Khatun
Argitaratua: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
nork: Bishakha, Adwiza Chakraborty
Argitaratua: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
nork: Islam, S.M. Zahidul
Argitaratua: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
nork: Khandker, Tahia Anjum
Argitaratua: (2024)